Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Cash (2018 - 2025)

Historic Change in Cash for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$73.1 million.

  • Bicycle Therapeutics' Change in Cash fell 372.19% to -$73.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$242.5 million, marking a year-over-year decrease of 17608.41%. This contributed to the annual value of $353.1 million for FY2024, which is 8800.16% up from last year.
  • Bicycle Therapeutics' Change in Cash amounted to -$73.1 million in Q3 2025, which was down 372.19% from -$71.5 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Change in Cash registered a high of $504.4 million during Q2 2024, and its lowest value of -$86.5 million during Q1 2025.
  • For the 5-year period, Bicycle Therapeutics' Change in Cash averaged around $27.0 million, with its median value being -$22.3 million (2022).
  • As far as peak fluctuations go, Bicycle Therapeutics' Change in Cash plummeted by 131966.87% in 2022, and later soared by 215487.61% in 2023.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Change in Cash stood at $179.2 million in 2021, then crashed by 112.46% to -$22.3 million in 2022, then plummeted by 104.63% to -$45.7 million in 2023, then skyrocketed by 75.16% to -$11.3 million in 2024, then crashed by 544.74% to -$73.1 million in 2025.
  • Its last three reported values are -$73.1 million in Q3 2025, -$71.5 million for Q2 2025, and -$86.5 million during Q1 2025.